Back to search
Neurogenic Hypertension
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Neurogenic Hypertension trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Neurogenic Hypertension trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
An open-label study to characterize the effects of mild, moderate, and severe Hepatic Impairment (HI) on the pharmacokinetics (PK) of ampreloxetine following a…
A double-blind study to characterize the effect of ampreloxetine on cardiac repolarization in healthy subjects.